A distinct inflammatory profile marked by neutrophil activity and cytokine elevation may underline poor biological response ...

Apogee Therapeutics Inc. (NASDAQ:APGE) is one of the best hot stocks to buy according to Wall Street analysts. Earlier in May ...

Biological drugs have been a game-changer for people with severe asthma, helping them breathe easier and live more ...

Depemokimab significantly reduces asthma exacerbations, benefiting patients regardless of their baseline asthma control levels. A biologics license application for depemokimab is currently being ...

Etokimab (I-Mab Biopharma), which is optimized for common IL-33 gene polymorphisms, has completed patient recruitment in its ...

Biological drugs have improved the lives of many people with severe asthma. However, a new study from Karolinska Institutet ...

Biologics, including medications like mepolizumab and dupilumab, are widely prescribed for patients with severe asthma and ...

While biological drugs or biologics have improved the lives of many people with severe asthma, a new study shows that some ...

Biologic drugs, made mainly from antibodies, have transformed the approach to treating chronic inflammatory diseases such as ...

Recommended management of asthma, including appropriate diagnostic steps and use of fractional exhaled nitric oxide (FeNO) in ...

On May 6, 2025, the Global Initiative For Asthma (GINA) published the 2025 update to their Global Strategy for Asthma ...

Doctors and patients should rigorously evaluate diagnosis and treatment compliance before turning to biologics, two ...